Skip to main content

Intratumoral Administration of INT230-6 Improves Drug Diffusion and Uptake into Cancer Cells in Patients with Advanced Solid Tumors

Web Exclusives, Emerging Therapies
Coming soon...

Related Items

Immune Checkpoint Inhibitors Do Not Increase Mortality in Patients with Cancer and COVID-19
Articles
Web Exclusives, AACR
Impact of COVID-19 on Cancer Screening and How We Can Get Back on Track
By Sheryl A. Riley, RN, OCN, CMCN
Articles
Cancer Screening and COVID-19, Web Exclusives
Novel CAR T-Cell Therapy Shows Promise in Relapsed or Refractory Multiple Myeloma
By Charlie Dawson
Articles
Web Exclusives, Multiple Myeloma
Intratumoral Administration of INT230-6 Improves Drug Diffusion and Uptake into Cancer Cells in Patients with Advanced Solid Tumors
Articles
Web Exclusives, Emerging Therapies
A Call to Focus on Financial Toxicity and Quality of Life in Genitourinary Malignancies
Articles
Web Exclusives, ASCO
ctDNA May Be a Biomarker for Postsurgery MRD Positivity and Relapse in Patients with NSCLC
Articles
Web Exclusives, Lung Cancer, AACR
ctDNA May Be a Biomarker for Postsurgery MRD Positivity and Relapse in Patients with NSCLC
Articles
Web Exclusives, FDA Approvals, News & Updates
Luspatercept Effective in Patients with Lower-Risk Myelodysplastic Syndromes
Articles
FDA Approvals, News & Updates, Web Exclusives
Tazverik Receives FDA Approval as First Treatment Specifically for Metastatic or Locally Advanced Epithelioid Sarcoma
Articles
Web Exclusives, FDA Approvals, News & Updates
FDA Grants Approval to Avapritinib for Patients with GIST
Articles
Web Exclusives, FDA Approvals, News & Updates